Evidence map›Paper›PMID 40136892›Full record

ReviewGels (Basel, Switzerland)2025

Novel Soft Dosage Forms for Paediatric Applications: Can We 3D-Print Them or Not?

Antoni Białek, Julia Krysztofiak, Aleksandra Hozakowska, Zuzanna Wojszel, Tomasz Osmałek, Monika Wojtyłko, Anna Froelich

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Pediatrics 4.0: the Transformative Impacts of the Latest Industrial Revolution on Pediatrics.Health care analysis : HCA : journal of health philosophy and policy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Antoni BiałekStudent's Research Group of Pharmaceutical Technology, The Student Scientific Society of Poznan University of Medical Sciences, 5 Rokietnicka Street, 60-806 Poznań, Poland.ORCID 0000-0001-8838-2805
Julia KrysztofiakStudent's Research Group of Pharmaceutical Technology, The Student Scientific Society of Poznan University of Medical Sciences, 5 Rokietnicka Street, 60-806 Poznań, Poland.ORCID 0000-0002-7158-4870
Aleksandra HozakowskaStudent's Research Group of Pharmaceutical Technology, The Student Scientific Society of Poznan University of Medical Sciences, 5 Rokietnicka Street, 60-806 Poznań, Poland.
Zuzanna WojszelStudent's Research Group of Pharmaceutical Technology, The Student Scientific Society of Poznan University of Medical Sciences, 5 Rokietnicka Street, 60-806 Poznań, Poland.
Tomasz OsmałekChair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806 Poznań, Poland.ORCID 0000-0002-6939-2888
Monika WojtyłkoChair and Department of Pharmaceutical Technology, 3D Printing Division, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806 Poznań, Poland.
Anna FroelichChair and Department of Pharmaceutical Technology, 3D Printing Division, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806 Poznań, Poland.ORCID 0000-0002-1491-1329

Funding

National Science Center 2021/42/E/NZ7/00125 (ID: 526262)
6 · The paper itself

Abstract

Over the past years, numerous novel dosage forms, including gels, have been investigated for paediatric treatment due to the need to provide flexible dose adjustment possibilities, as well as a patient-friendly approach to drug delivery. Simultaneously, 3D printing technology is continuously advancing and gaining interest as a tool for personalised formulation development. Multiple additive manufacturing methods, including the semi-solid extrusion, especially used in gel printing, provide flexibility regarding the dose of active ingredients and the adjustment of the design of soft dosage forms. 3D printing techniques can be considered as a possible answer to the demand for medicines tailored to small patients' needs. This review intends to present an overview of the current possibilities, comparing gel-like and non-gel-formulated dosage forms and crucial aspects of developing those cutting-edge dosage forms by 3D printing. This paper discusses soft formulations such as chewing gums, which still require extensive evaluation, and explores the question of the three-dimensional printing process. Furthermore, it highlights soft dosage forms, such as gel-based gummies and hydrogels, for which 3D fabrication has been intensively studied in previous years. However, the research still needs to advance.

Indexed as

3D-printingchocolategel printinggelsgummiespaediatric formulationssemi-solid extrusionsoft dosage forms

Identifiers

PMID40136892
PMCPMC11942176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.